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Signaling from endosomes is emerging as a mechanism by which selected receptors provide sustained signals distinct
from those generated at the plasma membrane. The activity of natural killer (NK) cells, which are important effectors of
innate immunity and regulators of adaptive immunity, is controlled primarily by receptors that are at the cell surface.
Here we show that cytokine secretion by resting human NK cells is induced by soluble, but not solid-phase, antibodies
to the killer cell immunoglobulin-like receptor (KIR) 2DL4, a receptor for human leukocyte antigen (HLA)-G. KIR2DL4
was constitutively internalized into Rab5-positive compartments via a dynamin-dependent process. Soluble HLA-G was
endocytosed into KIR2DL4–containing compartments in NK cells and in 293T cells transfected with KIR2DL4.
Chemokine secretion induced by KIR2DL4 transfection into 293T cells occurred only with recombinant forms of
KIR2DL4 that trafficked to endosomes. The profile of genes up-regulated by KIR2DL4 engagement on resting NK cells
revealed a proinflammatory/proangiogenic response. Soluble HLA-G induced secretion of a similar set of cytokines and
chemokines. This unique stimulation of resting NK cells by soluble HLA-G, which is endocytosed by KIR2DL4, implies
that NK cells may provide useful functions at sites of HLA-G expression, such as promotion of vascularization in
maternal decidua during early pregnancy.
Citation: Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, et al. (2006) Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS
Biol 4(1): e9.
Introduction
Natural killer (NK) cells are a subset of lymphocytes that
mediate innate immunity and regulate adaptive immunity via
cytokine secretion and cytotoxic activity. The activation of
NK cell function is a result of the integration of activating
and inhibitory signals delivered by NK cell receptors [1,2]. NK
cell receptors recognize ligands that are either up-regulated
or expressed constitutively on target cells. Cells can become
sensitive to NK cell–mediated cytotoxicity for various
reasons, such as loss of major histocompatibility complex
(MHC) class I expression or up-regulation of surface
molecules in response to DNA damage or stress, which can
occur as a result of infection or transformation [3,4]. Normal
cells are resistant to NK cell-mediated cytotoxicity due to the
presence of inhibitory receptors on the surface of NK cells
that recognize major histocompatibility complex (MHC) class
I molecules. The interaction between inhibitory receptors
and their MHC ligands on target cells transduces a negative
signal that blocks the lytic activity of NK cells. NK cells in
peripheral blood represent 5%–10% of circulating lympho-
cytes. In contrast, NK cells are the predominant lymphocyte
subset in uterus. In early pregnancy, uterine NK cells
proliferate and remain in the decidua basalis, which consists
of uterine tissue at the maternal–fetal interface [5]. The
precise function of uterine NK cells is still unknown.
Both peripheral blood and uterine human NK cells express
killer cell immunoglobulin-like receptors (KIR), a family of
NK cell receptors that recognize MHC class I molecules. KIR
are type I transmembrane glycoproteins with two or three Ig-
like domains and cytoplasmic tails of varying lengths [6]. KIRs
with long cytoplasmic domains (KIR2DL and KIR3DL) are
inhibitory receptors that contain cytoplasmic immunorecep-
tor tyrosine-based inhibition motifs (ITIM). Those KIRs with
short cytoplasmic domains (KIR2DS and KIR3DS) are
activating receptors that associate with the adapter DAP12
via a lysine residue in their transmembrane region. With one
exception, KIR genes are not expressed in all NK cells.
Rather, each NK cell expresses its own repertoire of KIR
genes.
KIR2DL4 is an evolutionarily conserved, framework mem-
ber of the KIR gene family that is expressed by all KIR
haplotypes and in all NK cells. In contrast to other activating
or inhibitory KIR family members, which regulate NK cell
cytotoxicity and cytokine production, KIR2DL4 activates
cytokine production, but not cytotoxicity, in resting NK cells
from peripheral blood [7]. It is unique in its genomic
organization and regulation and in its protein structure and
function [7–12]. KIR2DL4 is polymorphic with two reported
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genetic variants, designated 10A and 9A [13]. While the
product of the 10A allele is detectable on the cell surface, the
9A allele, encoding a protein with a truncated cytoplasmic
tail, is not stable at the cell surface [14]. KIR2DL4 has a
charged arginine residue in its transmembrane region;
however, unlike other activating KIR2DS that pair with the
adapter DAP-12, KIR2DL4 can associate with the FceRI c
chain [15]. Engagement of KIR2DL4 results in activation
despite the inhibitory potential conferred by the presence of
an ITIM in its cytoplasmic tail [7,16,17]. In resting, peripheral
blood NK cells, ligation of KIR2DL4 with monoclonal
antibody (mAb) results in interferon (IFN)-c production but
not cytotoxicity [7]. The very low cell surface expression of
KIR2DL4 [14,17] has been difﬁcult to reconcile with the
functional outcome associated with this receptor.
Data suggest that KIR2DL4 binds the nonclassical class I
molecule HLA-G [8,9]. HLA-G, a nonclassical class I molecule
of limited polymorphism, has a unique expression pattern
restricted mainly to trophoblast cells that invade the
maternal decidua during early pregnancy [18]. HLA-G
expression may be inducible in other cell types, in response
to inﬂammation, infection, and transformation [19]. Several
isoforms of HLA-G are expressed in the placenta, including
membrane-bound forms (HLA-G1, -G2, -G3, and -G4) and
soluble forms (HLA-G5 and -G6) [20]. Whereas membrane
HLA-G expression in trophoblast cells is restricted to
extravillous trophoblast cells, which invade the maternal
decidua, expression of soluble HLA-G was detected in all
types of placental trophoblast cells [21]. To date, the precise
role of HLA-G in the placenta remains unclear [22]. A
common hypothesis proposes that expression of HLA-G on
invading trophoblast cells is needed to prevent NK cell attack
[9,23]. However, this might not be necessary as trophoblast
cells are intrinsically resistant to NK cell–mediated lysis [24].
An alternative hypothesis proposes that trophoblast–NK cell
interactions regulate expression of cytokines by NK cells to
promote remodeling of the maternal vasculature, which is
required to establish adequate blood supply to the fetus
[5,25,26]. The beneﬁt of NK cell activation during early
pregnancy is supported by genetic studies on preeclampsia, a
potentially fatal disease due to incomplete remodeling of
spiral arteries by trophoblast cells. Resistance to preeclamp-
sia correlated with combinations of fetal HLA genes and
maternal KIR genes that seem to favor NK cell activation over
NK cell inhibition [27].
In mice as well, NK cells are present in the uterine mucosa
where they increase in number after implantation and
become activated as decidualization occurs [28]. In both mice
and humans, uterine NK cells have limited cytotoxic potential
but produce cytokines including IFN-c and tumor necrosis
factor (TNF)-a [20,29]. In several different strains of
genetically manipulated mice that lack NK cells, decidual
integrity is compromised and spiral artery modiﬁcation is
minimal. In addition, IFN-c produced by mouse uterine NK
cells has been implicated in the remodeling of the vasculature
of the maternal arteries necessary for a normal pregnancy
[30]. The signals that induce activation of uterine NK cells are
still unknown.
Results presented here support a role for KIR2DL4 in the
activation of NK cells at sites of soluble HLA-G expression.
Unlike other members of the KIR family, KIR2DL4 is
localized predominantly in endosomes and mediates endo-
cytosis of its ligand, soluble HLA-G. Furthermore, engage-
ment of KIR2DL4 by soluble ligand activates a
proinﬂammatory/proangiogenic response, consistent with a
role in promoting vascularization during early pregnancy.
Results
Interferon-c Secretion Is Induced by Soluble, but Not
Plate-Coated, or Bead-Bound Antibodies to KIR2DL4
Resting NK cells typically express very low or undetectable
levels of KIR2DL4 on the cell surface. Activation of NK cells
with interleukin (IL)-2 and feeder cells resulted in a transient
increase in the level of cell surface KIR2DL4 (Figure 1A). The
increase usually peaked between 7 and 14 days, and by 3
weeks in culture, receptor levels were no longer detectable.
However, despite low surface levels of KIR2DL4 on resting
NK cells, secretion of IFN-c was observed upon engagement
by anti-KIR2DL4 mAbs [7]. Three different mAbs (IgG1 33
and IgM 36 and 64) in solution, and even puriﬁed Fab of mAb
33, could enhance IFN-c secretion in the absence of cross-
linking with secondary antibodies [7] (Figure 1B and
unpublished data). In contrast, plate-coated or bead-bound
mAb 33 did not enhance IFN-c secretion (Figure 1B). The lack
of stimulation by cross-linked antibodies was not due to
induction of cell death, as determined with annexin-V–FITC
and propidium iodide to detect apoptotic and necrotic cells
(unpublished data). Activation by soluble antibodies to
KIR2DL4 was in direct contrast to the response to other
NK cell receptors such as CD16 or 2B4 (CD244), for which
soluble antibodies were not sufﬁcient to trigger a response,
and cross-linking by plate-coating or by binding to beads was
required to obtain comparable IFN-c release (Figure 1B and
unpublished data).
Dynamin-Dependent Endocytosis of KIR2DL4
Activation by soluble antibodies to KIR2DL4, despite
negligible receptor expression at the cell surface, could be
explained if KIR2DL4 were actively endocytosed into resting
NK cells. To examine the subcellular distribution of
KIR2DL4, both resting and activated NK cells were ﬁxed,
permeabilized, stained with KIR2DL4-speciﬁc mAb 33, and
analyzed by confocal microscopy. Most of the receptor resides
in vesicular structures, in contrast to other KIR receptors
such as KIR2DL1, which is detectable at the cell surface
(Figure 2A). To test if active endocytosis was a mechanism for
delivery of KIR2DL4 into intracellular compartments, resting
NK cells were incubated with Cy3-conjugated mAb 33 at 37 8C
for different times prior to analysis by confocal microscopy.
As shown in Figure 2B, at 30 min, some of the KIR2DL4 had
begun to internalize, and by 120 min, extensive endocytosis of
KIR2DL4 was detected by the presence of the 33-Cy3 mAb in
intracellular vesicles. The staining of internalized KIR2DL4 at
120 min was very similar to that detected by intracellular
staining for total KIR2DL4 (Figure 2A). Endocytosis was also
seen with the Fab portion of the KIR2DL4-speciﬁc mAb 33,
ruling out Fc receptor–mediated internalization of mAb 33
(Figure 2B).
An intracellular, vesicular pattern of KIR2DL4 distribution
was also observed after stable transfection of gfp-tagged
KIR2DL4 in the human embryonic kidney cell line 293T
(Figure 2C, center). In addition, good co-localization of anti-
2DL4 mAb 33 and gfp-tagged KIR2DL4 was observed,
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validating the speciﬁcity of the staining (Figure 2C). Uptake of
mAb 33 was also detected in 293T-2DL4-gfp cells (Figure 2D).
Endocytosis of KIR2DL4 was not induced by mAb-mediated
cross-linking, because the puriﬁed Fab portion of mAb 33 was
also endocytosed (Figure 2D). In both instances, mAb was
internalized to the same compartments where endogenous
KIR2DL4-gfp was localized (Figure 2D). These data show that
KIR2DL4 can also be endocytosed in non-NK cells.
Next, we tested whether endocytosis of KIR2DL4 was
dependent on the GTPase dynamin, a central player in
clathrin-mediated endocytosis [31]. The endocytosis assay was
performed in transfected 293T cells expressing HA-tagged
KIR2DL4 and either wild-type gfp-tagged dynamin or a
dominant-negative mutant (K44A) of gfp-tagged dynamin,
which competes for dynamin function due to a defect in GTP
binding and hydrolysis [32]. Cells were incubated with Cy3-
conjugated anti-KIR2DL4 mAb 33 for 2 h and processed for
confocal imaging. Cells expressing dynamin were identiﬁed
by ﬂuorescence of gfp. Whereas endocytosed KIR2DL4 could
be seen in vesicular structures in the presence of wild-type
dynamin, dynamin K44A hindered the transport of KIR2DL4
into vesicles and caused a striking redistribution of the
receptor at the plasma membrane (Figure 3).
To visualize endocytic compartments containing KIR2DL4
at higher resolution, the NK cell line NKL and the NK cell line
YTS stably transfected with KIR2DL4-gfp (YTS-2DL4-gfp)
were loaded with mAb 33 for 120 min at 37 8C. Cells were
ﬁxed, incubated with horseradish peroxidase (HRP)-conju-
gated secondary antibodies, and reacted with 3,39-diamino-
benzidine substrate. Electron micrographs revealed HRP
reaction product mainly in vesicles that ranged between 250
and 500 nm in size in both NKL and YTS-2DL4-gfp cells
(Figure 4A). The majority of HRP-reactive vesicles contained a
rim of HRP reaction product and an electron-lucent central
region characteristic of early endosomes. Some of the vesicles
also had more electron-dense content (Figure 4A). There was
negligible vesicular staining of cells not loaded with mAb 33
(unpublished data). Staining of a few tubular structures and
multivesicular bodies was also observed, consistent with
localization in a subset of recycling endosomes and lysosomes,
respectively (unpublished data). Thus, electron microscopy
conﬁrmed the vesicular localization of endocytosed KIR2DL4.
Confocal microscopy was performed with YTS-2DL4-gfp
cells to test how KIR2DL4-containing vesicles relate to
perforin-containing cytotoxic granules. Anti-perforin anti-
bodies decorated vesicles in YTS-2DL4-gfp cells that were
distinct from KIR2DL4-containing vesicles (Figure 4B). The
lack of overlap was conﬁrmed by Z-stack/three-dimensional
reconstruction studies (unpublished data). Resting NK cells
co-stained with mAb 33 and anti-perforin antibodies also
revealed no overlap of KIR2DL4 with perforin (unpublished
data). Lack of overlap was also seen with antibodies to
Figure 1. IFN-c Secretion by Resting NK Cells Is Induced by Soluble Antibodies to KIR2DL4
(A) KIR2DL4 expression on the surface of NK cells immediately after isolation (day 0) or after 7, 14, or 21 d in culture with autologous feeder cells and rIL-
2. Cells were stained with mAb 33.
(B) Resting NK cells were incubated with soluble (10 lg/ml), plate-coated (5 lg/0.1 ml/well), or bead-bound (4 beads/cell) antibodies to KIR2DL4 (mAb
33) or CD16 (mAb 3G8). After 24 h, culture supernatants were tested by ELISA for IFN-c production.
DOI: 10.1371/journal.pbio.0040009.g001
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granzyme A (unpublished data). The chemokine RANTES
resides in specialized storage vesicles in T cells [33]. Confocal
experiments revealed that RANTES was also in vesicular
compartments in NK cells but that those compartments were
distinct from vesicular compartments containing KIR2DL4
(unpublished data).
KIR2DL4 Resides in Rab5þ Early Endosomes
Co-localization of KIR2DL4 with a number of markers for
endocytic and lysosomal compartments was tested in resting
NK cells and in 293T-2DL4-gfp cells. Rab5 and its effector
EEA-1 are markers for early endosomes; mannose 6-phos-
phate receptor (M6PR) is a marker for late endosomes; and
lysosome-associated membrane protein 1 (LAMP-1) is a
marker for lysosomes. Resting NK cells were ﬁxed, permea-
bilized, and stained with anti-KIR2DL4 mAb 33 and with
Alexa-488–conjugated secondary antibodies, followed by
Figure 2. KIR2DL4 Is Endocytosed into Intracellular Vesicles
(A) The B cell line 721.221 (221), resting NK cells, and activated NK cells were fixed, permeabilized, and stained with Cy3-conjugated mAb 33. In the
image on the right, resting NK cells were fixed, permeabilized, and stained with a polyclonal antibody specific for the tail of KIR2DL1, followed by Alexa-
568–conjugated secondary antibodies.
(B) Resting NK cells were incubated at 37 8C for 30 min or 120 min with KIR2DL4-specific mAb 33-Cy3, with a Fab of control mAb 2A8 or with a Fab of
anti-KIR2DL4 mAb 33, as indicated. Cells were then fixed and analyzed by confocal microscopy.
(C) The 293T cells stably transfected with KIR2DL4-gfp (293T-2DL4-gfp) were fixed, permeabilized, and stained with anti-KIR2DL4 mAb 33 followed by
Alexa-568–conjugated secondary antibodies to show co-localization with KIR2DL4-gfp. Single confocal sections are shown.
(D) The 293T-2DL4-gfp cells were incubated at 37 8C for 120 min with anti-KIR2DL4 mAb 33, either intact (33 whole Ab) or as a Fab (33-Fab). Cells were
fixed, stained with Alexa-568–conjugated secondary antibodies, and analyzed by confocal microscopy. Single confocal sections are shown.
DOI: 10.1371/journal.pbio.0040009.g002
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staining with antibodies against Rab5, EEA-1, or M6PR and
with Alexa-568–conjugated secondary antibodies (Figure 5
and unpublished data). The 293T-2DL4-gfp cells were stained
for the same endocytic markers and KIR2DL4 was visualized
by gfp ﬂuorescence. In both resting NK cells and 293T-2DL4-
gfp cells, signiﬁcant overlap of staining was obtained only in
the case of Rab5 (Figure 5). Even though Rab5 and EEA-1
identify early endosomes, the overlap of staining of KIR2DL4
with EEA-1 was more limited. This was conﬁrmed by three-
color confocal analysis to detect KIR2DL4, Rab5, and EEA-1
in the same cells (unpublished data). Likewise, there was
limited overlap of KIR2DL4 staining with M6PR (Figure 5)
and LAMP-1 (unpublished data).
Members of the Rab GTPase family, such as Rab4, Rab5,
Rab7, and Rab11, occupy distinct yet overlapping membrane
domains on early and recycling endosomes and serve as
determinants of organelle identity [34]. Rab5 is a key
regulator of transport to early endosomes; Rab4 and Rab11
are implicated in recycling, from endosomes back to the
plasma membrane; and Rab7 has a role in the late endocytic
pathway and in lysosome biogenesis. To show unequivocally
that KIR2DL4 co-localizes with Rab5 and to address the
speciﬁcity of this co-localization, gfp-tagged versions Rab4,
Rab5, Rab7, and Rab11 were co-expressed with HA-tagged
KIR2DL4 in 293T cells. The cells were stained with anti-HA
antibodies followed by Alexa-568–conjugated secondary anti-
bodies, and confocal images were obtained. As seen pre-
viously with endogenous Rab5 (Figure 5), all KIR2DL4-
containing vesicles corresponded to Rab5-positive compart-
ments (Figure 6). In contrast, overlap with compartments
containing other Rab proteins was minimal (Figure 6). Thus,
KIR2DL4 resides in Rab5-containing subcompartments of the
early endocytic pathway.
KIR2DL4 Binds Both Membrane and Soluble Forms of
HLA-G
Soluble, recombinant Ig-fusion proteins of KIR2DL4
bound to cells expressing high levels of HLA-G [8,9].
However, one study could not reproduce these results [35],
and soluble forms of HLA-G have not bound to NK cells [36]
or to KIR2DL4 [35]. Failure to detect this interaction may
reﬂect an intrinsic low afﬁnity, as was previously noted for
interactions between activating KIR and their HLA ligands
[37,38]. The speciﬁcity of interaction between KIR2DL4 and
HLA-G was explored further using mAbs to MHC class I and
KIR2DL4 to block binding of KIR2DL4-Ig fusion proteins to
cells expressing HLA-G. Background binding of KIR2DL4-Ig
to 721.221 cells, which lack all classical HLA class I genes, was
not inhibited by anti-class I mAbs but was reduced by anti-
KIR2DL4 mAb 33 (Figure 7). In contrast, the enhanced
binding of KIR2DL4-Ig to transfected 721.221 cells expressing
membrane-bound HLA-G (221-G) was blocked by mAb DX17,
a pan–class I antibody known to block KIR–HLA class I
interactions [39], by the HLA-G–speciﬁc mAb G233, and by
Figure 3. Internalization of KIR2DL4 Is Dynamin Dependent
The 293T cells transfected with HA-tagged KIR2DL4 together with either
wild-type dynamin-gfp (Dynamin Egfp-WT) or a dominant-negative
mutant of dynamin (dynamin Egfp-K44A) were loaded with KIR2DL4-
specific Cy3-conjugated mAb 33 for 120 min and fixed. Individual
confocal sections are shown.
DOI: 10.1371/journal.pbio.0040009.g003
Figure 4. Immunolocalization of Endocytosed KIR2DL4 in NK Cells by
Electron Microscopy
(A) The NK cell lines NKL and YTS-2DL4-gfp were loaded with anti-
KIR2DL4 mAb 33 for 120 min. Endocytosed receptor was detected using
HRP-conjugated sheep anti-F(ab9)2 mouse IgG. The HRP reaction product
visible as a dark stain identifies the location of endocytosed KIR2DL4.
Vesicular structures positive for KIR2DL4 ranged between 250 and 500
nm in size.
(B) The NK cell line YTS, stably transfected with KIR2DL4-gfp (YTS-2DL4-
gfp), was fixed, permeabilized, and stained with antibody to perforin
followed by Alexa-568–conjugated secondary antibodies. Single confocal
sections are shown.
DOI: 10.1371/journal.pbio.0040009.g004
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the KIR2DL4-speciﬁc mAb 33 (Figure 7). Thus, binding was
blocked using speciﬁc mAbs to either KIR2DL4-Ig fusion
protein or HLA-G expressed on 221-G cells.
We explored the possibility that soluble HLA-G may be a
natural ligand of KIR2DL4. To date, evidence that HLA-G
binds directly to KIR2DL4 is lacking. Soluble HLA-G
produced in Escherichia coli and refolded with b2-micro-
globulin and the peptide KGPPAALTL was tested for
endocytosis into KIR2DL4-containing compartments. HLA-
Cw3 produced in E. coli and refolded with b2-microglobulin
and peptide GAVDPLLAL was used as a speciﬁcity control.
This refolded HLA-C preparation bound to KIR2DL2 by
surface plasmon-resonance analysis [40] (and P. Sun, personal
communication). Staining of 721.221 cells expressing HLA-
Cw3 with F4/326 is also included (Figure 8A) to show that the
mAb can detect HLA-Cw3 in ﬁxed and permeabilized
samples. Resting NK cells were loaded with either refolded
HLA-G or refolded HLA-Cw3 for 2 h. Internalized soluble
Figure 5. KIR2DL4 Resides in Endocytic Compartments
Resting NK cells and 293T-2DL4-gfp cells were fixed, permeabilized, and stained with antibodies against Rab5, EEA-1, and M6PR, followed by Alexa-568–
conjugated secondary antibodies. NK cells were further stained with mAb 33 coupled to Alexa-488 to detect KIR2DL4.
DOI: 10.1371/journal.pbio.0040009.g005
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HLA-G, but not HLA-Cw3, was detected in intracellular
vesicles (Figure 8A). It was difﬁcult to show unambiguous co-
localization of KIR2DL4 and HLA-G in resting NK cells,
possibly because HLA-G bound to KIR2DL4 interfered with
the staining of KIR2DL4 by mAb 33. Therefore, co-local-
ization experiments were done with the NK cell line YTS that
was stably transfected with gfp-tagged KIR2DL4. Endocytosed
HLA-G was detected in intracellular vesicles that contained
gfp-tagged KIR2DL4 (Figure 8B). Extensive co-localization of
refolded HLA-G and KIR2DL4-gfp was also seen after
incubation for 2 h with 293T-2DL4-gfp cells (Figure 8C). As
seen with resting NK cells, refolded HLA-Cw3 was not
detected in compartments containing KIR2DL4-gfp in
293T-2DL4-gfp cells.
Soluble HLA-G can be produced by alternative splicing [41]
and from cell surface–expressed HLA-G by proteolytic
cleavage [42]. Transfected 721.221 cells expressing mem-
brane-bound HLA-G (221-G) or secreted HLA-G (221-sG)
were mixed with untransfected 293T cells and with 293T cells
stably expressing KIR2DL4-gfp. After 48 h of co-culture, cells
were gently washed and the adherent 293T-2DL4-gfp cells
were ﬁxed, permeabilized, and stained with the HLA-G–
speciﬁc mAb G233. No internalization of HLA-G occurred
after co-culture with 221 cells (Figure 8A). In contrast, co-
culture with either 221-G or 221-sG resulted in internal-
ization of HLA-G in KIR2DL4-containing vesicles. Note the
Figure 6. KIR2DL4 Localizes to a Subset of Endosomes Containing Rab5
The 293T cells were transfected with HA-tagged KIR2DL4 and gfp-tagged
versions of Rab4, Rab5, Rab7, and Rab11. Forty hours after transfection,
cells were fixed and stained with anti-HA mAb, followed by Alexa-568–
conjugated secondary antibodies to detect KIR2DL4. Single confocal
sections are shown.
DOI: 10.1371/journal.pbio.0040009.g006
Figure 7. Binding of KIR2DL4-Ig Fusion Proteins to HLA-G–Expressing
Cells Is Blocked by Anti-KIR2DL4 and Anti-HLA Class I mAbs
(Top) 221-G cells were stained with mAb DX17 (pan–HLA class I mAb)
and mAb G233 (HLA-G–specific mAb) (solid lines). Staining with
secondary antibody alone is also shown (dotted lines).
(Bottom) The 221 and 221-G cells were incubated with 50 lg/ml
KIR2DL4-Ig fusion protein in the presence of 20 lg/ml of either isotype-
matched control Abs or mAbs specific for class I (DX17), HLA-G (G233), or
KIR2DL4 (33). Cells were then stained with goat anti-human IgG1
secondary antibodies and assessed by flow cytometry. The data are
expressed as mean fluorescence intensity (MFI).
DOI: 10.1371/journal.pbio.0040009.g007
Figure 8. Cell Surface Shed and Secreted, Soluble HLA-G Is Endocytosed into KIR2DL4-Containing Vesicles
(A) Endocytosis of soluble HLA-G in resting NK cells. The 221 cells and 221 cells transfected with HLA-Cw3 (221-Cw3) were fixed, permeabilized, and
stained with mAb F4/326. Resting NK cells were incubated at 37 8C for 120 min with soluble, refolded HLA-C or HLA-G. Cells were then fixed,
permeabilized, and stained with reagents to detect HLA-C (F4/326) or HLA-G (G233) as indicated.
(B) The NK cell line YTS-2DL4-gfp was loaded at 37 8C for 120 min with refolded HLA-G. Cells were fixed, permeabilized, and stained with mAb G233 to
detect co-localization of soluble HLA-G with gfp-tagged KIR2DL4.
(C) Recombinant soluble molecules of HLA-G but not HLA-C are endocytosed into 293T-2DL4-gfp cells. Refolded HLA-G and HLA-C were incubated with
293T-2DL4-gfp cells for 2 h. Cells were then fixed, permeabilized, and stained with either mAb G233 (to detect endocytosed HLA-G; upper) or mAb F4/
326 (to detect endocytosed HLA-C; middle).
(D) The 293T-2DL4-gfp cells were co-cultured with an equal number of 221 cells, 221 cells expressing transmembrane HLA-G (221-G), and 221 cells
expressing a soluble isoform of HLA-G (221-sG) for 48 h. Adherent 293T-2DL4-gfp cells were fixed, permeabilized, and stained with mAb G233 followed
by Alexa-568–conjugated secondary antibodies prior to acquisition of confocal images. Two 221-G cells are visible in the middle panel.
DOI: 10.1371/journal.pbio.0040009.g008
PLoS Biology | www.plosbiology.org January 2006 | Volume 4 | Issue 1 | e90076
NK Cell Activation by Receptor Endocytosis
PLoS Biology | www.plosbiology.org January 2006 | Volume 4 | Issue 1 | e90077
NK Cell Activation by Receptor Endocytosis
vesicular staining of endocytosed HLA-G in 293T-2DL4-gfp
cells in contrast to the cell surface staining of HLA-G on the
221-G cells included for comparison (Figure 8A, middle row,
left panel). No HLA-G was detected in untransfected 293T
cells co-cultured with 221-G and 221-sG cells (unpublished
data). Therefore, soluble HLA-G produced by shedding from
the cell surface or by secretion of an alternatively spliced
form is internalized by KIR2DL4 into endosomes.
To further quantify the interaction of KIR2DL4 with
soluble HLA-G, a recombinant, single-chain HLA-G (sHLA-
G) expressed in Chinese hamster ovary (CHO) cells was used.
This single-chain HLA-G contains an HLA-G–binding pep-
tide (RLPKDFVDL), the extracellular domains (a1, a2, a3) of
HLA-G, and b2-microglobulin all connected via linkers [43].
293T-2DL4-gfp cells were incubated for 2 h with sHLA-G at
37 8C. Cells were ﬁxed, permeabilized, and stained with mAb
G233. Vesicular staining of sHLA-G, which co-localized with
gfp-tagged KIR2DL4, was visible, similar to that seen after
incubation with soluble anti-2DL4 mAb 33 (Figure 9A). The
ﬂuorescence intensity of endocytosed sHLA-G was quantiﬁed
and compared to that of KIR2DL4-gfp in 293T cells. The
expectation was that sHLA-G uptake should increase with
higher expression levels of KIR2DL4-gfp. Red ﬂuorescence in
vesicles was compared to the green ﬂuorescence of KIR2DL4-
gfp in 38 individual cells (Figure 9B). The correlation between
the level of expression of gfp-tagged KIR2DL4 and the extent
of sHLA-G loading was highly signiﬁcant (p  0.0001).
To test whether KIR2DL4 was involved in sHLA-G
internalization, sHLA-G was incubated with 293T-2DL4-gfp
cells in the presence of anti-KIR2DL4 mAb 33, which blocks
KIR2DL4 binding to HLA-G on cells (Figure 7). Internal-
ization of sHLA-G was blocked in the presence of mAb 33,
whereas mAb 33 was still internalized in the presence of
sHLA-G (Figure 9A and 9C). Similar results were obtained in
YTS-2DL4-gfp cells (unpublished data). To test whether
sHLA-G interacts directly with KIR2DL4, sHLA-G was loaded
in the presence of soluble KIR2DL4-Ig fusion protein. Soluble
KIR2DL1-Ig fusion protein with speciﬁcity for a subset of
HLA-C alleles was used as a control. Soluble KIR2DL4-Ig
prevented the uptake of sHLA-G into 293T-2DL4-gfp cells,
whereas soluble KIR2DL1-Ig had no effect (Figure 9A and
9C). These results imply a direct interaction between soluble
forms of HLA-G and KIR2DL4.
Engagement of KIR2DL4 by Soluble Ligand Induces a
Unique Profile of Cytokine/Chemokine Secretion
We had shown previously that resting NK cells could be
stimulated with anti-KIR2DL4 mAbs to secrete IFN-c [7]. To
get further information on the transcriptional response
activated by this receptor, exploratory DNA microarray
experiments were performed. Freshly isolated resting NK
cells were stimulated either with control, isotype-matched,
soluble antibodies or with KIR2DL4–speciﬁc soluble IgM
mAbs for 5 h. Among the approximately 14,000 genes
examined, all the genes that were up-regulated greater than
2-fold in resting NK cells from at least two of three
independent donors are listed in Figure 10A. Interestingly,
only a small subset of genes showed up-regulation. They
include an array of proinﬂammatory/proangiogenic cyto-
kines, such as IL-6, IL-1b, TNF-a, and IL-23 (comprised of the
IL-23a and IL-12b subunits), and chemokines, such as IL-8,
MIP-3a, MIP-1d, MIP-1a, and MIP-2b.
The KIR2DL4-induced expression of the majority of these
genes was conﬁrmed by semiquantitative RT-PCR analysis of
RNA isolated at different timepoints after stimulation of
resting NK cells by either control or anti-KIR2DL4 mAbs
(Figure 10B). Such a time course analysis highlighted differ-
ences in the kinetics of responses. Transcription of the GRO3
and COX-2 genes was up-regulated transiently, whereas all of
the other genes examined showed sustained expression up to
the 16 h timepoint. Responses detectable within the ﬁrst two
hours included TNF-a, IL-1b, IL-8, MIP-3a, and GRO-3. In
contrast, transcription of IL-6, IL-12b(p40), IL-23a(p19),
COX-2, and MARCKS increased only after 2 h. Previous
work [7] and Figure 1B show that stimulation by KIR2DL4
induces IFN-c production. However, IFNG gene transcription
was up-regulated only approximately 1.5-fold in the micro-
array studies and therefore did not score as positive. RT-PCR
analysis reconciled this apparent discrepancy, as induction of
IFNG transcription occurred only 8 h after stimulation. The
time course of IFN-c protein secretion supported the
transcriptional data (Figure 10C). There is delayed secretion
of IFN-c compared to other cytokines such as TNF-a and IL-
1b. IFNG gene transcription is a late response, which requires
de novo protein synthesis, as it was inhibited by cyclo-
heximide (Y. T. Bryceson, unpublished observation). Thus,
exploratory microarray analysis using anti-KIR2DL4 mAbs to
stimulate resting NK cells revealed the up-regulation of a
select number of proinﬂammatory/proangiogenic cytokine
and chemokine genes. However, it is possible that stimulation
of KIR2DL4 by a natural ligand, such as soluble HLA-G,
induces a different response.
To test whether a natural ligand of KIR2DL4 could conﬁrm
the observed transcriptional responses induced by anti-
KIR2DL4 mAbs, protein expression was tested after incuba-
tion of resting NK cells with soluble HLA-G. Resting NK cells
were incubated with sHLA-G produced in mammalian cells
and tested for secretion of a number of cytokines and
chemokines. As speciﬁcity control for activation by soluble
HLA-G, mAb G233, which blocks the interaction between
HLA-G and KIR2DL4 (Figure 7), was used. As shown in Figure
Figure 9. Endocytosis of Soluble HLA-G into 293T-2DL4-gfp Cells Is Blocked by Anti-KIR2DL4 mAb and by Soluble KIR2DL4
(A) Recombinant, soluble, sHLA-G at 50 lg/ml or mAb 33 (50 lg/ml) was incubated with 293T-2DL4-gfp cells. sHLA-G was also incubated together with
50 lg/ml mAb 33, 50 lg/ml KIR2DL1-Ig, or 50 lg/ml KIR2DL4-Ig, as indicated on the left. Cells were fixed, permeabilized, and stained with either Alexa-
568–conjugated secondary antibodies to detect mAb 33 or anti-HLA-G mAb G233, as indicated. Individual confocal sections are shown.
(B) Uptake of sHLA-G into 293T-2DL4-gfp cells correlates with level of KIR2DL4 expression. Red fluorescence intensity of G233 staining and green
fluorescence intensity of gfp were quantified in 38 individual cells and plotted on a log scale. A best-fit line was generated by linear regression analysis
using EXCEL data analysis software.
(C) Ratio of red to green fluorescence was quantified for each loading condition as indicated. Average of 10 cells is shown, and standard deviation is
shown as bars.
DOI: 10.1371/journal.pbio.0040009.g009
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11, soluble KIR2DL4-speciﬁc mAb and sHLA-G activated the
secretion of cytokines and chemokines, for which transcrip-
tional activation had been observed in DNA microarrays.
Responses induced by sHLA-G were inhibited by anti–HLA-G
mAb G233 but not by an isotype-matched control IgG.
Among the three donors tested, quantitative variation in
protein secretion was observed. To take such variability into
account, the amount of cytokine/chemokine induced by
sHLA-G was compared to that induced by anti-KIR2DL4
mAb for each donor separately. For six of eight cytokines/
chemokines tested, sHLA-G induced at least 50% of the
amount induced by anti-KIR2DL4 mAb (Figure 11). To
further evaluate the speciﬁcity of responses, secretion of IL-
5, IL-12 (which shares the IL-12b p40 subunit with IL-23), and
IL-13 was also determined. NK cells can produce IL-5 and IL-
13 under certain conditions but have not been reported to
produce IL-12. No secretion of any of these three cytokines
was induced by anti-KIR2DL4 and by sHLA-G (unpublished
data). Therefore, soluble HLA-G activates a qualitatively and
quantitatively similar cytokine/chemokine response as
KIR2DL4-speciﬁc mAb.
To test whether the KIR2DL4-induced response was
unique, responses elicited by CD16 cross-linking were
evaluated in parallel. Anti-CD16 mAb attached to beads
induced secretion of only a subset of the cytokines/chemo-
kines induced by KIR2DL4 engagement (Figure 11). Very
little or no secretion of IL-6, IL-8, and IL-23 was induced by
CD16 cross-linking. Therefore, activation of KIR2DL4 by
soluble ligand induces secretion of a unique proﬁle of
proinﬂammatory/proangiogenic mediators, which may be
relevant to functional interaction between KIR2DL4 on
uterine NK cells and HLA-G produced by trophoblast cells.
KIR2DL4 Induces IL-8 Secretion in 293T Cells
The 293T cells are capable of producing IL-8, as TLR-4
agonists induced IL-8 secretion in TLR-4–transfected 293T
cells [44]. As KIR2DL4 engagement in resting NK cells
resulted in secretion of IL-8, the ability of KIR2DL4 to
induce IL-8 secretion in 293T cells was tested. Transfected
293T cells expressing receptors 2B4 and gp49B were used for
comparison. Expression of KIR2DL4, but not 2B4 or gp49B,
in 293T cells induced IL-8 secretion (Figure 12A). As 293T
cells did not stain with anti-HLA-G mAb G233 (see Figure 8D
and unpublished data), IL-8 secretion may be induced by
KIR2DL4 expression alone, independent of ligand binding.
IL-8 expression in KIR2DL4-transfected 293T cells was used
as a convenient assay to test mutants of KIR2DL4 (Figure 12B)
for their ability to signal in 293T cells. A KIR2DL4 molecule
lacking the arginine residue in the transmembrane region
Figure 10. Binding of Soluble mAb to KIR2DL4 Up-regulates Multiple Genes in Resting NK Cells
(A) All genes exhibiting greater than 2-fold up-regulation in microarray experiments with resting NK cells of at least two of three different individuals are
listed.
(B) Semiquantitative RT-PCR was performed on total RNA isolated at different time points from resting NK cells stimulated with either control IgM mAbs
or anti-KIR2DL4 IgM mAbs 36 and 64.
(C) Time course of TNF-a, IL-1b, and IFN-c secretion by resting NK cells stimulated with anti-KIR2DL4 mAbs 36 and 64 (open symbols) or control IgM
mAbs (closed symbols). Squares and triangles represent data obtained from two different donors. Protein secretion was detected by ELISA.
DOI: 10.1371/journal.pbio.0040009.g010
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[2DL4(RY-GT)] was tested. This arginine may contribute to
KIR2DL4 pairing with the FceRI c chain [15], similar to other
activating receptors that carry a charge in the transmem-
brane region. Second, a truncated KIR2DL4 (2DL4-TR),
lacking its cytoplasmic tail, was tested. Confocal microscopy
showed that both of these mutants were targeted to endocytic
vesicles in 293T cells, similar to wild-type KIR2DL4 (unpub-
lished data), showing that the cytoplasmic tail of KIR2DL4 is
not required for endosomal targeting. Secretion of IL-8 was
obtained with the 2DL4(RY-GT) mutant (Figure 12C), show-
ing that the charged amino acid in the transmembrane region
is not required for signaling. In contrast, the 2DL4-TR
mutant did not signal for IL-8 secretion (Figure 12C), despite
its localization in endosomes, pointing to a role for the
transmembrane region and/or cytoplasmic tail in signaling.
These results suggested that the natural 9A allele of KIR2DL4,
which encodes a receptor with a truncated cytoplasmic tail,
would not signal for IL-8 secretion. A frameshift mutation
was introduced in wild-type KIR2DL4 cDNA in order to
produce a molecule identical to the KIR2DL4 9A allotype:
consistent with the truncated mutant, expression of the 9A
mutant in 293T cells did not induce IL-8 secretion (unpub-
lished data).
Another mutant was informative with respect to the
signaling function of KIR2DL4. A chimeric, HA-tagged
receptor containing the extracellular regions of gp49B fused
to the transmembrane and cytoplasmic domains of KIR2DL4
was expressed at the surface of 293T cells and did not trafﬁc
to endosomes (Figure 12B), indicating that the luminal
domain of KIR2DL4 is required for proper targeting. No
IL-8 secretion was induced by this chimeric gp49B/2DL4, even
after stimulation for 12 h with beads coated with anti-HA
antibodies (Figure 12D). Cross-linking HA-tagged 2B4 with
the same beads on 2B4-transfected 293T cells resulted in a
very modest increase in IL-8 secretion. These results suggest
that endosomal localization of KIR2DL4 is required for its
signaling function.
Discussion
The NK cell receptor KIR2DL4 emerges as an activation
receptor speciﬁc for soluble HLA-G. Constitutive endocytosis
of KIR2DL4 occurs in freshly isolated, resting NK cells, in IL-
2–activated NK cells, in NK cell lines, and in 293T cells
transfected with KIR2DL4. At steady state, most of KIR2DL4
is intracellular, which explains the difﬁculty in detecting cell
surface receptor by ﬂow cytometry. Endocytosis explains also
the unusual property of KIR2DL4 to induce cytokine and
chemokine secretion in response to soluble mAbs and to
soluble HLA-G, in the absence of further cross-linking, but
not in response to solid-phase mAbs (either plate-coated or
bead-bound). Therefore, lack of detectable KIR2DL4 at the
cell surface should not be taken as evidence for a lack of
function. Endocytosed KIR2DL4 showed extensive co-local-
ization with Rab5, a GTPase that marks a subset of early
endosomes.
Endosomes have emerged recently as a specialized signaling
compartment [45,46]. Some endocytosed receptors, such as
the epidermal growth factor receptor and Toll-like receptor 9,
signal from endosomes [45–47]. It is thought that endocytic
vesicles carry signaling platforms where endocytosed recep-
tors link with downstream signaling molecules and provide
sustained signaling [45]. Our data strongly support signal
transduction by KIR2DL4 in endosomes. First, KIR2DL4 is
actively internalized into endosomes, where most of KIR2DL4
resides at steady state. Second, solid-phase Abs to KIR2DL4
did not induce IFN-c secretion, indicating that cross-linking
Figure 11. Cytokine/Chemokine Synthesis Induced by Soluble HLA-G in
Resting NK Cells
Resting NK cells (5 3 105 cells/well) from three different donors were
incubated separately for 48 h with either soluble, control IgM Ab (cIg),
soluble anti-KIR2DL4 IgM mAb 36 (anti-2DL4), soluble HLA-G produced in
CHO cells (sHLA-G), or beads coated with control anti-HA IgG1 mAb
16B12 (cIg) or with anti-CD16 IgG1 mAb 3G8 (3G8), as indicated. sHLA-G
was used together with control IgG2a mAb (cIg) or with anti-HLA-G
IgG2a mAb G233 (G233), as indicated. Secretion of the cytokines/
chemokines listed on the left is given in pg/ml for each donor separately.
Secretion induced by sHLA-G and by Ab-coated beads was compared to
that induced by anti-KIR2DL4 mAb for each donor separately and is
expressed as a percentage of the anti-KIR2DL4 response. The graphs
represent the average 6 standard deviation from three experiments.
DOI: 10.1371/journal.pbio.0040009.g011
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KIR2DL4 at the cell surface does not result in signaling. Third,
expression of KIR2DL4 and of KIR2DL4 mutants in 293T cells
resulted in secretion of IL-8 only for those receptors that were
targeted to endosomes. A chimeric receptor with the trans-
membrane region and cytoplasmic tail of KIR2DL4 that
remained at the cell surface did not activate IL-8 secretion,
even after cross-linking at the cell surface. Extensive co-
localization of endocytosed KIR2DL4 with a subset of early
endosomes that carry the small GTPase Rab5 is interesting, as
Rab5 was recently assigned a role in endosomal signaling by
the epidermal growth factor receptor and by Toll-like
receptor 9 [45,46]. The signaling pathway triggered by
KIR2DL4 requires further study. Ligand-bound KIR2DL4
must somehow be distinguished from free, endogenous
KIR2DL4 in NK cells, as resting NK cells do not respond to
KIR2DL4 until soluble ligand is added. This distinction may
not be made in transfected 293T cells, which appear to
respond to KIR2DL4 in the absence of a ligand. Thus,
KIR2DL4 signaling is subject to tight regulation in NK cells.
Signaling by KIR2DL4 in 293T cells also implies that
immunoreceptor tyrosine-based activation motif (ITAM)-
containing subunits, such as the FceRI c chain, are unlikely
to be necessary. This conclusion is further supported by the
lack of requirement for the arginine residue in the trans-
membrane region of KIR2DL4 for signaling in 293T cells.
Unlike other NK cell activation receptors with charged
residues in the transmembrane region, such as NKG2D and
NKp46, which require a partner chain for transport out of
the endoplasmic reticulum, KIR2DL4 is readily transported
to the cell surface and to endosomes, even in the absence of a
known adapter. The position of the arginine at the fourth
amino acid position from the N-terminus of the trans-
membrane region, rather than deeper into the lipid bilayer,
suggests that membrane insertion may not be compromised
[48]. However, induction of cytotoxicity by IL-2–activated NK
cells through KIR2DL4 in a redirected lysis assay had been
dependent on the arginine-tyrosine motif in the trans-
membrane region of KIR2DL4 [8]. It is therefore likely that
KIR2DL4 can signal in different ways, for cytokine secretion
independent of an arginine-mediated association (this study),
and for cytotoxicity through an arginine-mediated associa-
tion with the FceRI c chain [8,15]. The biological context in
which KIR2DL4-mediated cytotoxicity would occur is not
clear. On the other hand, stimulation of a proinﬂammatory
or proangiogenic response by soluble HLA-G could be a
useful property in various physiological contexts. In partic-
ular, our study supports a new model for the role of NK cells
in early pregnancy.
A ligand of KIR2DL4 is the nonclassical MHC class I
molecule HLA-G, which is produced naturally in soluble form
by alternative splicing [41,49] and by proteolytic cleavage of
membrane-bound HLA-G [42]. In vitro studies have shown
that HLA-G induces apoptosis of T cells, inhibition of
alloproliferation of T cells and unfractionated mononuclear
cells, and inhibition of NK cell cytotoxicity [19,42,50,51]. In
contrast, HLA-G stimulated proliferation and cytokine
secretion in uterine NK cells [29]. In this study, four different
soluble forms of HLA-G have been internalized into
Figure 12. IL-8 Secretion Induced by KIR2DL4 Is Independent of the Transmembrane Arginine Residue and Requires Trafficking to Intracellular Vesicles
(A) Expression of KIR2DL4 in 293T cells induces IL-8 secretion. The 293T cells were transfected with HA-tagged 2B4, gp49B, and KIR2DL4. After 48 h,
culture supernatants were tested for IL-8 by ELISA.
(B) Schematic representation of KIR2DL4 variants used in this study. Receptor localization was determined by confocal analysis of immunofluorescence
staining of 293T cells transfected with the indicated constructs for 48 h.
(C) IL-8 secretion induced by KIR2DL4 mutants in 293T cells. The 293T cells were transfected with HA-tagged KIR2DL4, KIR2DL4(RY-GT), and KIR2DL4-TR.
After 48 h, culture supernatants were tested for IL-8 by ELISA. Transfection efficiency was verified by monitoring HA-positive cells by confocal
microscopy.
(D) Cell surface–expressed gp49B/2DL4 chimera does not induce IL-8 secretion. The 293T cells were transfected with HA-tagged 2B4, KIR2DL4, and
gp49B/2DL4 chimera, as indicated. After 48 h, beads coated with control IgG (solid bars) or anti-HA mAb (hatched bars) were added at four beads per
cell. Twelve hours later, culture supernatants were tested for IL-8 secretion. The percentage of 293T cells expressing receptor at the cell surface was
monitored by HA staining and flow cytometry, and was as follows: vector control, 2%; 2B4, 39%; KIR2DL4, 9%; gp49B, 31%; gp49B/2DL4, 26%.
DOI: 10.1371/journal.pbio.0040009.g012
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KIR2DL4-containing endosomes. HLA-G shed from the cell
membrane and the naturally secreted form of HLA-G, each
produced in transfected 721.221 cells, were endocytosed into
KIR2DL4-containing compartments of co-cultured cells. In
addition, recombinant HLA-G, produced in E. coli and
refolded with b2-microglobulin and peptide, was also
internalized, as was an sHLA-G produced in transfected
CHO cells. Competition for HLA-G uptake with a soluble,
recombinant KIR2DL4-Ig fusion protein established, for the
ﬁrst time, a direct interaction between KIR2DL4 and HLA-G.
So far, evidence for KIR2DL4 binding to HLA-G had been
indirect. Binding of soluble KIR2DL4-Ig fusion proteins to
cells expressing high levels of HLA-G [8,9] had been detected,
but binding of soluble HLA-G tetramers to NK cells or
soluble HLA-G to KIR2DL4 in surface plasmon resonance
studies had not been detected [35,36]. The detection of
KIR2DL4–HLA-G interaction may have been possible here
due to accumulation of soluble HLA-G into KIR2DL4-
containing endosomes.
In pregnancy, tolerance of the semiallogeneic fetus by the
maternal immune system has long presented an immuno-
logical paradox [52,53]. To avoid rejection of the fetus, several
factors must regulate maternal responsiveness to fetal
alloantigens. Regulatory mechanisms may include inhibitory
receptors on lymphocytes that bind ligands on fetal cells
[5,54] and suppression of T lymphocytes by tryptophan
catabolism via indoleamine-2,3-dioxygenase activity [55]. An
alternate and nonexclusive view is that interactions of fetal
cells with immune cells at the maternal–fetal interface play a
role in proper implantation by shaping vascular adaptations
of the surrounding maternal tissue via cytokine secretion
[25,56]. Uterine tissue in early human pregnancy is charac-
terized by extensive vascular remodeling, by invasion of HLA-
G–expressing trophoblast cells, and by an abundance of
maternal NK cells. Engagement of KIR2DL4 by soluble ligand
induced a proﬁle of gene transcription and protein secretion
that is consistent with a proangiogenic response. The
controversial role of HLA-G expression on extravillous
cytotrophoblast cells—be it for inhibition or activation of
maternal NK cells—may be settled in favor of activation of
NK cells through soluble HLA-G for the purpose of vascular
remodeling. Successful implantation and placentation re-
quire vascular endothelial growth factor, an angiogenic
growth factor that is secreted by trophoblast cells throughout
gestation [57]. The products of several genes up-regulated on
NK cells by KIR2DL4 engagement, including TNF-a, IL-1b,
and IFN-c, induce vascular endothelial growth factor pro-
duction in trophoblast cells, thereby inﬂuencing uterine
angiogenesis [58]. Another gene induced by KIR2DL4 in NK
cells, COX-2, is a rate-limiting enzyme in prostaglandin
biosynthesis, which is required for uterine angiogenesis
during implantation in mice [59]. In addition, IL-8 is known
to induce neovascularization in tumor and viral models
[60,61]. Secretion of IL-23, which is encoded by IL12B and
IL23A genes, was also up-regulated by KIR2DL4 engagement
with soluble ligands. Selective induction of these two genes
occurs in mouse uterine NK cells at gestation day 6 [62]. In
summary, the spectrum of proangiogenic mediators that are
induced in resting NK cells by soluble HLA-G and by anti-
KIR2DL4 mAb supports a role for KIR2DL4 in facilitating
implantation and neovascularization during pregnancy. Our
data, together with evidence that secretion of soluble HLA-G
by in vitro fertilized human embryos is associated with a
higher pregnancy rate [63,64] and that reduced levels of
soluble HLA-G during early pregnancy correlate with a
higher incidence of preeclampsia [65], suggest that KIR2DL4
has a positive role in reproductive success.
The description of soluble HLA-G expression in other cell
types and tissues, such as erythroblasts during erythropoiesis
[66], suggests the interesting possibility that a KIR2DL4-
mediated signal in NK cells could serve a proinﬂammatory or
proangiogenic function in other contexts as well. In this study,
we show that constitutive internalization of KIR2DL4 results
in uptake of soluble HLA-G and accumulation into endocytic
compartments where the bulk of KIR2DL4 resides. Binding of
soluble agonist by KIR2DL4 has the potential advantage of
promoting speciﬁc NK cell responses without the complicat-
ing contribution of multiple receptor–ligand interactions that
occur during cell–cell contacts, which engage a wide array of
activating and inhibitory NK cell receptors.
Materials and Methods
Cell lines and culture. The 293T cells were obtained from ATCC
(American Type Culture Collection, Manassas, Virginia, United
States); YTS cells expressing an ecotropic receptor were a gift from
G. Cohen (Harvard Medical School, Boston, Massachusetts, United
States); NKL cells were a gift from M. Robertson (Indiana University
School of Medicine, Indianapolis, Indiana, United States); and 221-
HLA-Cw3 cells were a gift from J. Gumperz and P. Parham (Stanford
University, Palo Alto, California, United States). The 221-HLA-G cells
that do not express HLA-E [54] (referred to here as 221-G) cells were
a gift from M. Lopez-Botet (University Pompeu Fabra, Barcelona,
Spain); 221 cells transfected with the soluble form of HLA-G (221-sG)
have been described previously [67]. NKL cells were cultured in RPMI
1640 medium containing 10% fetal calf serum, 1% l-glutamine, 1%
sodium pyruvate, and 200 U/ml of recombinant IL-2 (National Cancer
Institute–FCRDC, Frederick, Maryland, United States). All other cell
lines were cultured in Iscove’s medium supplemented with 10% fetal
calf serum and 1% l-glutamine.
Human polyclonal NK cells were isolated from peripheral blood
lymphocytes (PBL) using the MACS NK cell negative isolation kit
(Miltenyi Biotech, Auburn, California, United States). NK cells were
greater than 95% CD3 and CD56þ. These freshly isolated NK cells
(‘‘resting NK’’) were cultured in Iscove’s medium containing 10%
human serum without added IL-2 or feeders. ‘‘Activated NK’’ refers
to NK cell populations from a given donor that was expanded with
autologous irradiated PBL as feeders and IL-2, as described
previously [7].
The 293T cells were transiently transfected with LipofectAMINE
2000 according to the supplier’s instructions. The 293T-2DL4-gfp
cells are 293T cells that were stably transfected, using LipofectAMINE
2000, with a KIR2DL4 cDNA fused to gfp in the vector pBABE
(puro)CMVþ using SalI and BamH1 sites. Transfected cells were
selected and maintained in Iscove’s medium containing puromycin at
a concentration of 2 lg/ml. YTS-2DL4-gfp refers to YTS cells
transduced as described [68] to stably express the KIR2DL4-gfp
fusion protein.
Antibodies and reagents. mAbs to KIR2DL4, namely, 33 (IgG1), 36,
and 64 (IgM), were generated in our laboratory [7]. To prepare Fab
fragments, the 33 antibody was produced inmouse ascites ﬂuid and the
IgG1 was precipitated with 40% saturated ammonium sulfate and
puriﬁed from the precipitate by ion-exchange chromatography on
DEAE-Sepharose using an NaCl gradient. The IgG1 was then cleaved
with papain at an enzyme-to-antibody ratio (wt/wt) of 1:20 in 100 mM
Tris-HCl, 150 mM NaCl, 2 mM mercaptoethanol, 2 mM NaEDTA (pH
7.1) at 37 8C for 5 h. The reaction was quenched by addition of fresh
iodoacetamide to a ﬁnal concentration of 7.5 mM. Fab was puriﬁed
from the digestion mixture by DEAE-Sepharose chromatography. The
Fab fractions were pooled and concentrated in 20 mM Tris-HCl (pH
7.4). The integrity and purity of the Fab fragments were conﬁrmed by
SDS-PAGE analysis. The control Fab portion of IgG1mAb2A8, speciﬁc
for malaria protein PV525, was obtained from K. Singh (National
Institute of Allergy and Infectious Diseases [NIAID], National
Institutes of Health [NIH], Rockville, Maryland, United States).
Antibodies to CD16 (3G8), Rab5 (610457), and EEA-1 (BD61045)
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were purchased from Becton Dickinson (Franklin Lakes, New Jersey,
United States) Antibody to M6PR was purchased from Afﬁnity
Bioreagents (Golden, Colorado, United States), and antibody to
perforin was purchased from Endogen Pierce (Rockford, Illinois,
United States). An afﬁnity-puriﬁed polyclonal rabbit antibody
speciﬁc for the carboxy-terminal end of KIR2DL1 has been described
[69]. MAb DX17 speciﬁc for MHC class I was a gift from L. Lanier
(University of California San Francisco, California, United States),
and mAb G233 speciﬁc for HLA-G was a gift from A. Moffett
(Cambridge University, Cambridge, United Kingdom). MAb F4/326,
speciﬁc for HLA-C alleles, was a gift from S.-Y. Yang (New York
University, New York, New York, United States). Anti-HA mAb was
obtained from Cell Signaling (Beverly, Massachusetts, United States),
and all isotype control mAbs were obtained from Sigma (St. Louis,
Missouri, United States). All secondary goat anti-mouse antibodies
conjugated to either Alexa-Fluor 488 or Alexa-Fluor 564 were
obtained from Molecular Probes (Eugene, Oregon, United States).
Rab5-gfp, Dynamin Egfp-WT, and Dynamin Egfp-K44A mutant
constructs were obtained from J. Bonifacino (National Institute of
Child Health and Human Development, NIH). Constructs encoding
Rab4-gfp, Rab7-gfp, and Rab11-gfp cloned in pEgfp-C and C3 vectors
(Clontech, Palo Alto, California, United States) were obtained from
M. Zerial (Max Planck Institute for Molecular Cell Biology and
Genetics, Dresden, Germany). These constructs have been previously
described [70]. Expression constructs for transfection into 293T cells
consisted of cDNAs for 2B4 [71], mouse gp49B [72], KIR2DL4, and
KIR2DL4 variants cloned into the pDisplay vector (Stratagene, La
Jolla, California, United States) that introduces an HA-tag at the
amino-terminus. The KIR2DL4(RY-GT) construct was generated by
site-directed mutagenesis of R246G and Y247T. The truncated
KIR2DL4-TR was engineered by introduction of a stop codon at
position K269 and contains the amino acids CSKK at the carboxy-
terminus. The gp49B/2DL4 chimera was engineered using PCR to fuse
the extracellular domain of gp49B ending at S226 with the
transmembrane and tail of KIR2DL4 beginning at position S224.
The amino acids at the boundary are DQSS/SWPS.
KIR2DL1-Ig and KIR2DL4-Ig fusion proteins have been described
previously [8]. The recombinant, single-chain soluble HLA-G product
has been described [43] and was obtained from Organon NV (Oss, the
Netherlands). Bacterially expressed and refolded HLA-G was pro-
duced as described for HLA-E [73]. Refolded HLA-C has been
described [40] and was obtained from P. Sun (NIAID, NIH).
Immunostaining and confocal microscopy. Cells were allowed to
settle on poly-L-lysine–coated two-well culture slides (BioCoat, BD,
Bedford, Massachusetts, United States) for 30 min prior to ﬁxation in
PBS/4% paraformaldehyde. Nonspeciﬁc sites were saturated and cells
were permeabilized for 30 min with PBS/10% normal donkey serum/
0.5% Triton X-100. Cells were stained with the relevant primary
antibody for 1 h and revealed with goat anti-mouse or goat anti-
rabbit Alexa-Fluor–conjugated secondary antibodies in PBS/3%
normal donkey serum/0.5% Triton X-100. In some cases, cells were
stained with directly conjugated antibodies (e.g., 33-Cy3). Cells were
washed and mounted in slides using the Prolong Anti-fade kit
(Molecular Probes, Eugene, Oregon, United States).
Images were processed using a confocal laser-scanning microscope
(Axiovert 200M LSM 510 META; Zeiss, Jena, Germany) ﬁtted with a
1.3 Oil DIC Plan-Neoﬂuar 363 objective was used. Images were
acquired using channel mode, multitrack acquisition with the main
beam splitters HFT 488/543 for the excitation of gfp and Alexa-Fluor
568. Filter sets of BP 505–530 for gfp and LP560 for Alexa-Fluor 568
were used. Parameters were adjusted to yield scan control of ﬁxed
pixel density at 5123512 pixels, 12-bit pixel depth, and a pinhole size
of 90 lm. To quantify the co-localization of KIR2DL4 with loaded
soluble HLA-G, the LSM 510 imaging examiner software was used.
Electron microscopy. The NK cell lines NKL and YTS-2DL4-gfp
were loaded with KIR2DL4-speciﬁc Ab 33 for 2 h. Cells were rinsed in
HBSS before ﬁxation with periodate-lysine-paraformaldehyde (PLP)
ﬁxative containing 0.25% glutaraldehyde for 2 h at room temper-
ature. Cells were permeabilized with PBS containing 0.01% saponin
for 5 min at room temperature and incubated for 1 h with
peroxidase-conjugated F(ab9)2 sheep anti-mouse IgG (Jackson Immu-
noresearch Laboratories, West Grove, Pennsylvania, United States) in
PBS containing 0.01% saponin. Cells were rinsed in PBS and ﬁxed in
1.5% glutaraldehyde in 0.1 M sodium cacodylate (pH 7.0) plus 5%
sucrose for 1 h. Cells were then rinsed with 50 mM Tris-HCl (pH 7.4)
plus 7.5% sucrose before development with Immunopure Metal–
enhanced 3,39-diaminobenzidine substrate (Pierce, Rockford, Illinois,
United States). Cells were then rinsed three times with 50 mM Tris-
HCl, (pH 7.4) plus 7.5% sucrose before ﬁxation in 4% paraformalde-
hyde/2.5%glutaraldehyde in 100 mM sodium cacodylate buffer (pH
7.4). Cells were postﬁxed in 1% OsO4/1%K3Fe(CN)6, washed with
H2O, dehydrated in a graded ethanol series, and embedded in Spurr’s
resin. Thin sections were cut with an MT-7000 ultramicrotome (RMC,
Tucson, Arizona, United States). Samples were examined on a Hitachi
H7500 TEM at 80 kV and images were captured with a CCD camera
(Advanced Microscopy Technologies, Danvers, Massachusetts, United
States).
Cellular assays. For cytokine/chemokine assays, resting NK cells
were incubated with soluble mAbs at 10 lg/ml, plate-coated anti-
bodies (5 lg Ab/100 ll/well of a 96-well plate) or bead-bound
antibodies (1 lg antibody/4 3 107 beads; four beads per cell). For
soluble HLA-G stimulation of resting NK cells, recombinant single-
chain HLA-G (30 lg/ml) was used together with either control IgG2a
mAb or anti-HLA-G mAb G233 at 90 lg/ml. After the indicated
timepoints, supernatants were removed and tested for the presence
of cytokines by ELISA. ELISA kits for IL-1b, TNF-a, IL-6, IL-23, MIP-
3a, IL-12, IL-5, and IL-13 (R & D Systems, Minneapolis, Minnesota,
United States), IFN-c (Pierce), and IL-8 (Biosource, Camarillo,
California, United States) were used according to manufacturers’
instructions.
For endocytosis assays, resting NK cells, 293T-2DL4-gfp, or YTS-
2DL4-gfp cells were loaded with mAb 33 (10 lg/ml) or with 50 lg/ml
of soluble HLA-G for the indicated time periods at 37 8C. Cells were
then washed in PBS and plated onto chamber slides for immuno-
ﬂuorescence staining. For the blocking studies, mAb 33, KIR2DL4-Ig,
or KIR2DL1-Ig (50 lg/ml) was added at the same time as soluble HLA-
G.
Binding assays using Ig-fusion proteins were done essentially as
described previously [8,74]. For blocking studies, mAbs to MHC
molecules were added to the cells 20 min prior to the addition of
KIR2DL4-Ig fusion proteins. KIR2DL4-speciﬁc mAb 33 was preincu-
bated with KIR2DL4-Ig fusion proteins for 20 min prior to addition
to the 221 cells.
For microarray analysis, NK cells were stimulated with either
isotype control IgM antibodies (Sigma) or anti-2DL4 mAbs 36 and 64
for 5 h at 37 8C. Total RNA was puriﬁed from cell pellets by TriZOL/
chloroform extraction followed by column puriﬁcation (RNeasy Midi
Kit; Qiagen, Valencia, California, United States). The integrity of
isolated RNA was examined by denaturing TAE agarose gel electro-
phoresis. Direct labeling of ﬁrst-strand cDNA with Cy3-dUTP or Cy5-
dUTP (Amersham Pharmacia, Piscataway, New Jersey, United States),
respectively, was performed in oligo(dT) primed reverse transcrip-
tion reactions (SuperScript II Reverse Transcriptase; Invitrogen,
Carlsbad, California, United States). The remaining RNA was
degraded, and Cy3- and Cy5-labeled probes were combined and
puriﬁed by buffer exchange on Vivaspin 500 columns (10K cutoff;
Vivascience, Hannover, Germany). Labeled cDNA was hybridized to
14,000 oligonucleotide arrays (NIAID Microarray Facility, NIH).
Arrays were scanned on an Axon GenePix 4000B scanner (Axon
Instruments, Foster City, California, United States). Image analysis
was carried out using GenePix (Axon Instruments) and mAdb
(National Cancer Institute; http://madb.nci.nih.gov) software.
To investigate transcription of microarray candidate genes by RT-
PCR, speciﬁc primers were designed to amplify regions of approx-
imately 200 bp that spanned exon-intron boundaries. Total RNA was
isolated by TriZOL/chloroform extraction followed by column
puriﬁcation (RNeasy Mini Kit; Qiagen). First-strand cDNA was
synthesized with oligo(dT) primed SuperScript II reverse tran-
scriptase (Invitrogen) from 600 ng of total RNA, according to the
manufacturers’ protocol. PCRs were performed with Taq polymerase
according to the manufacturers’ protocol in 25 ll reactions. First-
strand cDNA template corresponding to 10 ng total RNA per
reaction were used in touch-down PCRs with ﬁve cycles (annealing
temperature 70 8C) followed by 20 to 35 cycles (annealing temper-
ature 65 8C). Primers to CCL20 (forward 59-CCAATGAAGGCTGT
GACATCAATG-39 and reverse 59-ACCTCCAACCCCAGCAAGGTTC-
39), CXCL3 (forward 59-TGCAGACACTGCAGGGAATTCAC-39 and
reverse 59-CTTCTCTCCTGTCAGTTGGTGCT-39), GAPD (forward
59-GGCATGGACTGTGGTCATGAG-39 and reverse 59-TGCACCAC
CAACTGCTTAGC-3 9) , IFNG ( forward 5 9-AGCGGATAA
TGGAACTCTTTTCTTAG-39 and reverse 59-AAGTTTGAAG
TAAAAGGAGACAATTTGG-39), IL1B (forward 59-TCCAGG
GACAGGATATGGAGCAA-39 and reverse 59-GCTTTTCCA
TCTTCTTCTTTGGGT-39), IL6 (forward 59-TCGGTACATCCTC
GACGGCATC-39 and reverse 59-ATACCTCAAACTCCAAAAGAC
CAG-39), IL8 (forward 59-CTGATTTCTGCAGCTCTGTGTGA-39 and
reverse 59-GGGTCCAGACAGAGCTCTCTTC-39), IL12B (forward
5 9-ACATTCTGCGTTCAGGTCCAGG-3 9 and reverse 5 9-
CTCCAAATTTTCATCCTGGATCAG-39), IL23A (forward 59-ACT
CAGTGCCAGCAGCTTTCAC-39 and reverse 59-CAGACCCTGGTG
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GATCCTTTGC - 3 9) , MARCKS ( f o r w a r d 5 9- GAGCAA
GCTTTTGTGAGATAATCG-39 and reverse 59-GAATGATTTGA
GATGGGATCTGTG-39), PTGS2 (forward 59-AATCATTCACCAGGC
AAATTGCTG-39 and reverse 59-CTTCCAACTCTGCAGACATTTCC-
39), and TNF (forward 59-CTCTTCTGCCTGCTGCACTTTGG-39 and
reverse 59-CCATTGGCCAGGAGGGCATTGG-39) were used.
PCR products were separated by horizontal agarose gel electro-
phoresis, stained with ethidium bromide, visualized with UV light,
and photographed. Black/white images were inverted with Adobe
Photoshop software (Adobe Systems, San Jose, California, United
States).
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